Title: Aromatase inhibitors act by lowering estrogen in the circulation and in tumor cells in postmenopausa
1- Aromatase inhibitors act by lowering estrogen in
the circulation and in tumor cells in
post-menopausal women
2Aromatase Inhibitors in Breast Cancer
3Clinical Trials with Aromatase Inhibitors
4Adverse Effects Associated with Anastrozole and
Tamoxifen in Trials
5Leuprolide (Lupron)
- GnRH analog
- continuous GnRH analog turns off the production
of gonadotropins (LH,FSH) and decreases
testosterone synthesis by 90-95 - slow release implantable devices (Duros) lasts
12 mos. - used to treat advanced prostate cancer
- cancer can escape and become androgen independent
after 18-36 mos.
6Concerns related to the success of chemotherapy
in curing primary cancer
- Quality of life fertility
- Increased risk secondary cancer
7Late Complications of Cancer Chemotherapy
8Testis Histology
after Chemo
Normal
9Risk of Secondary Cancer after Chemotherapy
10Combination Therapy Examples Hodgkins Disease
- MOPP
- mechlorethamine, vincristine, procarbazine,
prednisone - ABVD
- doxorubicin, bleomycin, vinblastine, dacarbazine
- Stanford V
- Mechlorethamine by vein once every 4 weeks
- Doxorubicin (Adriamycin) by vein every odd
week - Vinblastine (Velban) by vein every odd week
- Vincristine (Oncovin) by vein every even
week - Bleomycin (Blenoxane) by vein every even
week - Etoposide by vein 2 days in a row weeks 3,
7, 11 - Prednisone by mouth every other day
- high risk of secondary cancers, infertility
- lower risk contraindicated if heart or lung
disease - complex but may be better than ABVD
11DNA Microarray Analysis and Cancer Diagnosis
how does it work?
12blackdisease free at 5 yr
78 non-lymph node positive sporadic Breast CA
tumors were chosen
Tumors
white metastases
70 genes that were best discriminators
13Future of Gene Array Analysis in Chemotherapy
- 1. establish a prognosis directly from gene
expression - data on primary tumor sample--determine whether
adjuvant therapy is warranted? - 2. expression analysis may predict which tumors
will respond to which drugs